Accurate stratification of renal risk is important for the effective management of patients with type 2 diabetes. In a new study, Elley et al. report and validate a 5-year prediction model for the development of end-stage renal disease in patients with type 2 diabetes in primary care.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs
Cardiovascular Diabetology Open Access 31 August 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Heerspink, H. J. et al. Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. Eur. Heart J. 31, 2888–2896 (2010).
Drury, P. L. et al. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 54, 32–43 (2011).
Levey, A. S. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 80, 17–28 (2011).
Elley, C. R. et al. Derivation and validation of a renal risk score for people with type 2 diabetes. Diabetes Care http://dx.doi.org/10.2337/dc13-0190.
Jardine, M. J. et al. Prediction of kidney-related outcomes in patients with type 2 diabetes. Am. J. Kidney Dis. 60, 770–778 (2012).
Stevens, R. J. et al. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin. Sci. (Lond.) 101, 671–679 (2001).
Forsblom, C. et al. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J. Am. Soc. Nephrol. 22, 537–544 (2011).
Thomas, M. C., Viberti, G. & Groop, P. H. Screening for chronic kidney disease in patients with diabetes: are we missing the point? Nat. Clin. Pract. Nephrol. 4, 2–3 (2008).
Fraser, S. D. et al. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care. BMC Fam. Pract. 14, 88 (2013).
Kausz, A. T., Guo, H., Pereira, B. J., Collins, A. J. & Gilbertson, D. T. General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J. Am. Soc. Nephrol. 16, 3092–3101 (2005).
Acknowledgements
M. C. Thomas's research is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thomas, M., Groop, PH. Assessing renal risk in patients with type 2 diabetes. Nat Rev Nephrol 9, 559–560 (2013). https://doi.org/10.1038/nrneph.2013.181
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.181
This article is cited by
-
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs
Cardiovascular Diabetology (2019)
-
Diabetic kidney disease
Nature Reviews Disease Primers (2015)
